|
|
Article: Nabi Biopharmaceuticals and Third Point Reach Agreement.
- Article from:
- PR Newswire
- Article date:
- November 13, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BOCA RATON, Fla. and NEW YORK, Nov. 13 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals and Third Point LLC today announced that they have reached a settlement ("Settlement Agreement") relating to a potential consent solicitation.
Under the terms of the Settlement Agreement, Nabi Biopharmaceuticals has appointed two Third Point nominees, Jason Aryeh, founder and general partner of JALAA Equities, LP and Tim Lynch, president and CEO of NeuroStat Pharmaceuticals, Inc., to the company's board of directors. In addition, Nabi Biopharmaceuticals will establish a strategic action committee ("SAC") to continue the company's previously announced process of exploring ...